DNA Methylation Clocks Predict Heart Disease Risk Better Than Chronological Age
Study of 12 epigenetic aging algorithms finds GrimAge clocks strongly predict cardiovascular disease and mortality in older adults.
Summary
Researchers analyzed 12 DNA methylation aging algorithms in 1,606 US adults aged 50+ from NHANES data. GrimAge-based clocks showed the strongest associations with heart disease risk and cardiovascular mortality. GrimAgeMortacc and GrimAge2Mortacc increased coronary heart disease risk by 115-176% per standard deviation increase. Five algorithms significantly predicted cardiovascular death, with GrimAge clocks showing 87-90% increased mortality risk. These epigenetic clocks may enhance cardiovascular risk assessment beyond traditional factors.
Detailed Summary
This comprehensive study represents the first systematic comparison of 12 widely-used DNA methylation aging algorithms for predicting cardiovascular disease risk and mortality. Using data from 1,606 US adults aged 50 and older in the National Health and Nutrition Examination Survey (1999-2002), researchers evaluated how well these epigenetic clocks predict heart disease outcomes.
The study examined two primary outcomes: self-reported cardiovascular disease prevalence and cardiovascular mortality over follow-up. DNA methylation was measured using advanced BeadChip technology, and researchers calculated age acceleration scores by comparing biological age estimates to chronological age.
GrimAge-based algorithms emerged as the most powerful predictors. GrimAgeMortacc and GrimAge2Mortacc showed particularly strong associations with coronary heart disease and heart attacks, with odds ratios ranging from 2.15 to 2.76 per standard deviation increase. For mortality prediction, five algorithms showed significant associations with cardiovascular death, including HannumAgeacc, PhenoAgeacc, ZhangAgeacc, and both GrimAge variants.
The findings remained consistent across different demographic groups, including various age ranges, sexes, and racial/ethnic categories. This suggests these epigenetic clocks could serve as universal biomarkers for cardiovascular risk assessment, potentially identifying high-risk individuals who might benefit from earlier intervention.
These results have important implications for personalized medicine and preventive cardiology. Unlike genetic risk scores that reflect fixed predisposition, DNA methylation patterns can change with lifestyle interventions, making them potentially actionable biomarkers for both risk prediction and monitoring treatment responses.
Key Findings
- GrimAge algorithms increased heart disease risk by 115-176% per standard deviation
- Five DNA methylation clocks significantly predicted cardiovascular mortality
- Associations remained consistent across age, sex, and racial groups
- GrimAge clocks showed 87-90% increased cardiovascular death risk
- Epigenetic age acceleration outperformed chronological age for risk prediction
Methodology
Cross-sectional and prospective cohort study using NHANES 1999-2002 data with Infinium Methylation EPIC BeadChip analysis. Researchers calculated odds ratios for disease prevalence and hazard ratios for mortality, adjusting for demographic and clinical variables.
Study Limitations
Study relied on self-reported cardiovascular disease data which may introduce bias. The cohort was limited to US adults aged 50+, potentially limiting generalizability to younger populations or other geographic regions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.